SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-010833
Filing Date
2012-11-02
Accepted
2012-11-01 17:38:40
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ili_10q-093012.htm 10-Q 1657438
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 19709
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 19776
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 8489
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 8460
  Complete submission text file 0001437749-12-010833.txt   11099687

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ipxl-20120930.xml EX-101.INS 2244461
7 XBRL TAXONOMY EXTENSION SCHEMA ipxl-20120930.xsd EX-101.SCH 80804
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipxl-20120930_cal.xml EX-101.CAL 50008
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipxl-20120930_def.xml EX-101.DEF 366857
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipxl-20120930_lab.xml EX-101.LAB 475747
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipxl-20120930_pre.xml EX-101.PRE 372336
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Filer) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34263 | Film No.: 121174533
SIC: 2834 Pharmaceutical Preparations